Instrument Inactif

Autres langues DANAHER Other OTC

Actions

FDA Approves Danaher Unit's Rapid Test for Hepatitis C	27/06
Danaher Schedules Second Quarter 2024 Earnings Conference Call	24/06
Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics	19/06
Danaher Corporation Announces Executive Changes	19/06
Danaher : The future of pathology is digital	18/06
2023 Danaher Summit Highlight: Valuing Diagnostics	13/06
2023 Danaher Summit Highlight: Overcoming Barriers	11/06
Danaher Appoints Martin Stumpe as Chief Data & Artificial Intelligence Officer	05/06
Danaher Names Martin Stumpe Chief Data & Artificial Intelligence Officer	05/06
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer	05/06
Danaher Corporation Appoints Martin Stumpe as Chief Data & Artificial Intelligence Officer	05/06
2023 Danaher Summit Highlights: AI and Data	30/05
Agilent lowers full-year revenue forecast on slowing demand from its biotech clients	29/05
Some of the biggest splits in Corporate America	23/05
Danaher Insider Sold Shares Worth $2,386,325, According to a Recent SEC Filing	17/05
Danaher Diagnostics Summit: Patient Access	16/05
Danaher Insider Sold Shares Worth $4,866,675, According to a Recent SEC Filing	15/05
Danaher Insider Sold Shares Worth $11,735,856, According to a Recent SEC Filing	13/05
Brain injury diagnostics: A patient’s perspective	10/05
Danaher, Johns Hopkins University to Develop Neurological Diagnostics	09/05

Aucun résultat pour cette recherche